Evidence map›Paper›PMID 27784725›Full record

ArticleJournal of lipid research2017

Characterization of homologous sphingosine-1-phosphate lyase isoforms in the bacterial pathogen Burkholderia pseudomallei.

Christopher J McLean, Jon Marles-Wright, Rafael Custodio, Jonathan Lowther, Amanda J Kennedy, Jacob Pollock, David J Clarke, Alan R Brown, Dominic J Campopiano

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.American journal of respiratory and critical care medicine · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Sphingolipid biosynthesis in man and microbes.Natural product reports · 2018
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher J McLeanEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Jon Marles-WrightInstitute of Quantitative Biology, Biochemistry, and Biotechnology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Rafael CustodioSchool of Biosciences, University of Exeter, Exeter EX4 4QD, United Kingdom.
Jonathan LowtherEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Amanda J KennedyEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Jacob PollockEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
David J ClarkeEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
Alan R BrownSchool of Biosciences, University of Exeter, Exeter EX4 4QD, United Kingdom.
Dominic J CampopianoEastChem School of Chemistry University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom Dominic.Campopiano@ed.ac.uk.
University of Edinburgh · GBUniversity of Exeter · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I013687/1Biotechnology and Biological Sciences Research Council BB/J01446X/1
6 · The paper itself

Abstract

Sphingolipids (SLs) are ubiquitous elements in eukaryotic membranes and are also found in some bacterial and viral species. As well as playing an integral structural role, SLs also act as potent signaling molecules involved in numerous cellular pathways and have been linked to many human diseases. A central SL signaling molecule is sphingosine-1-phosphate (S1P), whose breakdown is catalyzed by S1P lyase (S1PL), a pyridoxal 5'-phosphate (PLP)-dependent enzyme that catalyzes the cleavage of S1P to (2E)-hexadecenal (2E-HEX) and phosphoethanolamine. Here, we show that the pathogenic bacterium, Burkholderia pseudomallei K96243, encodes two homologous proteins (S1PL2021 and S1PL2025) that display moderate sequence identity to known eukaryotic and prokaryotic S1PLs. Using an established MS-based methodology, we show that recombinant S1PL2021 is catalytically active. We also used recombinant human fatty aldehyde dehydrogenase to develop a spectrophotometric enzyme-coupled assay to detect 2E-HEX formation and measure the kinetic constants of the two B. pseudomallei S1PL isoforms. Furthermore, we determined the X-ray crystal structure of the PLP-bound form of S1PL2021 at 2.1 Å resolution revealing that the enzyme displays a conserved structural fold and active site architecture comparable with known S1PLs. The combined data suggest that B. pseudomallei has the potential to degrade host SLs in a S1PL-dependent manner.

Indexed as

Aldehyde-LyasesBurkholderia pseudomalleiCrystallography, X-RayLysophospholipidsProtein ConformationProtein IsoformsPyridoxal PhosphateSphingolipidsSphingosineAldehyde-LyasesLysophospholipidsProtein IsoformsPyridoxal PhosphateSphingolipidsSphingosinesphingosine 1-phosphatesphingosine 1-phosphate lyase (aldolase)assayfatty aldehyde dehydrogenasepyridoxal 5′-phosphatesphingolipids

Identifiers

PMID27784725
PMCPMC5234717
OpenAlexW2539601550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.